Accès ouvert
2026
article
OpenAlex
Murat Özdede, Serap Yadigar, Alper Tuna Güven, Suat Akgür et autres
Background: Finerenone is associated with a lower, yet clinically relevant, risk of hyperkalemia compared with steroidal mineralocorticoid receptor antagonists in diabetic kidney disease (DKD) trials. However, real-world data on hyperkalemia and its associated factors are scarce. Methodology: FINE-TURK is a national, observational …
tr, kh, co, ag, kz, no, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Mustafa Arıcı, Kenan Ateş, Alaattin Yıldız, Ali Rıza Odabaş et autres
BACKGROUND: Chronic kidney disease (CKD) is a global public health problem with increasing disease burden affecting nearly 10% of adult population worldwide. We aimed to detect the prevalence of CKD, patients' distribution among CKD stages, and factors associated with having CKD in …
tr
(code pays fourni par la source)
2025
article
OpenAlex
Elif Arı, Serap Yadigar, Suat Akgür, Erkan Şengül
Background: This study aimed to evaluate the renal outcomes associated with finerenone use in a Turkish diabetic chronic kidney disease (CKD) cohort. Methods: This study demonstrated initial and first month data of adult participants with diabetic CKD who received finerenone in 34 …
kh, tr, ag
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ramazan Danış, Savaş Öztürk, Ismail Doruk Kocyigit, Jehat Kılıç et autres
BACKGROUND: The devastating earthquakes in Kahramanmaraş, Türkiye, in February 2024, caused extensive trauma and loss of lives, causing unique challenges in the management of earthquake-related crush syndrome. The current study investigates the prognostic value of pre-earthquake kidney function for mortality prediction in …
tr, kh, ag, co
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Ramazan Danış, Savaş Öztürk, Ismail Doruk Kocyigit, Jehat Kılıç et autres
tr, kh, Somalie, gb, co
(code pays fourni par la source)
2025
article
OpenAlex
Serap Yadigar, Pınar Gökmirza Özdemir, Erman Özdemir, Ömer Aydıner et autres
tr
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Bahar Arıcan Tarım, Francesco Fıcı, İstemihan Tengiz, Saadet Avunduk et autres
Purpose: Diabetes and dyslipidemia are leading causes of mortality and morbidity.According to international guidelines, statins are the cornerstone of treatment in patients with diabetes and/or dyslipidemia.However, statins and antidiabetic agents have opposite pharmacological effects, because statins, particularly atorvastatin and rosuvastatin, impair glucose …
tr, es, it
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Savaş Öztürk, Meltem Gürsu, Mustafa Arıcı, İdris Şahın et autres
INTRODUCTION: There are not enough data on the post-CO-VID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data of PD patients after COVID-19 with a control PD group. METHODS: This study, supported by …
tr
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Serhat Karadağ, Savaş Öztürk, Mustafa Arıcı, Numan Görgülü et autres
tr
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Meral Meşe, Elif Arı
OBJECTIVE: The purpose of this prospective study was to evaluate the clinical, laboratory, and donation-specific outcomes of living kidney donors 6 years after donation. METHODS: We included a total of 93 kidney donors and 54 age- and sex-matched individuals as control group …
tr
(code pays fourni par la source)
2022
conference-abstract
OpenAlex
Savaş Öztürk, Kenan Turgutalp, Mustafa Arıcı, Numan Görgülü et autres
Abstract BACKGROUND AND AIMS Haemodialysis (HD) patients are at increased risk for adverse short-term consequences of COVID-19. In this study, we investigated the characteristics of chronic HD patients in the post-COVID-19 period and compared them with the control group. METHOD We conducted …
tr
(code pays fourni par la source)
2022
conference-abstract
OpenAlex
Savaş Öztürk, Meltem Gürsu, Mustafa Arıcı, İdris Şahın et autres
Abstract BACKGROUND AND AIMS There is not enough data on the post-COVID-19 (coronavirus disease 2019) period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data retrospectively obtained in the follow-up of PD patients after …
tr
(code pays fourni par la source)